Risk for worsening heart failure and upgrade to cardiac resynchronization in mildly symptomatic and asymptomatic nonischemic cardiomyopathy patients receiving implantable cardioverter defibrillator

被引：0
|
作者：
Suzuki, A. [1 ]
Tsuyoshi, S. [1 ]
Yagishita, D. [1 ]
Yashiro, B. [1 ]
Ejima, K. [1 ]
Suzuki, T. [1 ]
Sato, T. [1 ]
Manaka, T. [1 ]
Shoda, M. [1 ]
Hagiwara, N. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [1] Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients
    Dhir, Sumer K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (03) : 257 - 258
  • [2] Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure
    Leclercq, Christophe
    Mabo, Philippe
    Trochu, Jean Noel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (23) : 1844 - 1846
  • [3] Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients
    Klein H.U.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (5) : 431 - 442
  • [4] Worsening Renal Function and Arrhythmic Event in Implantable Cardioverter Defibrillator Patients with Nonischemic Heart Failure
    Takahashi, Atsushi
    Shiga, Tsuyoshi
    Yagishita, Daigo
    Futagawa, Keisuke
    Serizawa, Naoki
    Yamada, Norihiro
    Suzuki, Tsuyoshi
    Ejima, Koichiro
    Satoh, Takahiro
    Manaka, Tetsuyuki
    Shoda, Morio
    Hagiwara, Nobuhisa
    CIRCULATION, 2008, 118 (18) : S988 - S988
  • [5] Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure
    Rami, T
    Shih, HT
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (03) : 264 - 269
  • [6] Role of cardiac resynchronization therapy in asymptomatic and mildly symptomatic heart failure
    Forcina M.S.
    Gold M.R.
    Current Heart Failure Reports, 2009, 6 (1) : 44 - 48
  • [7] Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure
    Abraham, WT
    Young, JB
    León, AR
    Adler, S
    Bank, AJ
    Hall, SA
    Lieberman, R
    Liem, LB
    O'Connell, JB
    Schroeder, JS
    Wheelan, KR
    CIRCULATION, 2004, 110 (18) : 2864 - 2868
  • [8] Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure
    Choi, Anthony J.
    Thomas, Sunu S.
    Singh, Jagmeet P.
    HEART FAILURE CLINICS, 2016, 12 (03) : 423 - +
  • [9] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
    Cavalcanti, Rafael
    Aboul-Hosn, Nael
    Morales, Gustavo
    Abdel-Latif, Ahmed
    ANGIOLOGY, 2018, 69 (04) : 297 - 302
  • [10] Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen, KA
    Levine, JH
    Berger, RD
    Daubert, JP
    Winters, SL
    Greenstein, E
    Shalaby, A
    Schaechter, A
    Subacius, H
    Kadish, A
    CIRCULATION, 2006, 113 (06) : 776 - 782
12345